Theratechnologies Files 6-K Report
| Field | Detail |
|---|---|
| Company | Theratechnologies Inc. |
| Form Type | 6-K |
| Filed Date | Sep 25, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: disclosure, foreign-private-issuer, press-release
TL;DR
Theratechnologies dropped a 6-K filing on 9/25/25 with a press release attached.
AI Summary
Theratechnologies Inc. filed a Form 6-K on September 25, 2025, reporting information for the month of September 2025. The filing includes a press release dated September 25, 2025, as Exhibit 99.1. The company is a foreign private issuer based in Montreal, Quebec, Canada, and its fiscal year ends on November 30.
Why It Matters
This filing provides an update on Theratechnologies' activities and regulatory disclosures for the period, which is important for investors tracking the company's ongoing operations and compliance.
Risk Assessment
Risk Level: low — This filing is a routine disclosure report (6-K) and does not contain significant new financial or operational information that would inherently increase risk.
Key Players & Entities
- Theratechnologies Inc. (company) — Registrant
- Jocelyn Lafond (person) — General Counsel and Corporate Secretary
- September 25, 2025 (date) — Filing and Press Release Date
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is filed by foreign private issuers to report information that they have made or are required to make public in their home country, have filed or are required to file with a stock exchange, or have distributed or are required to distribute to their security holders.
What is the primary document included in this 6-K filing?
The primary document included is Exhibit 99.1, a Press Release dated September 25, 2025.
Where is Theratechnologies Inc. headquartered?
Theratechnologies Inc. is headquartered in Montreal, Quebec, Canada.
When does Theratechnologies Inc.'s fiscal year end?
Theratechnologies Inc.'s fiscal year ends on November 30.
Who signed this Form 6-K on behalf of Theratechnologies Inc.?
Jocelyn Lafond, General Counsel and Corporate Secretary, signed the Form 6-K.
Filing Stats: 152 words · 1 min read · ~1 pages · Grade level 11.1 · Accepted 2025-09-25 14:02:29
Filing Documents
- d49314d6k.htm (6-K) — 8KB
- d49314dex991.htm (EX-99.1) — 10KB
- g49314g0925144401877.jpg (GRAPHIC) — 3KB
- 0001193125-25-217171.txt ( ) — 24KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. THERATECHNOLOGIES INC. By: /s/ Jocelyn Lafond Name: Jocelyn Lafond Title: General Counsel and Corporate Secretary Date: September 25, 2025